A university-based study finds a high prevalence of fibromyalgia symptoms, strongly linked to anxiety, stress, and lifestyle ...
Clinical Trials Arena on MSN
Axsome begins Phase III AXS-14 FORWARD trial for fibromyalgia management
Axsome Therapeutics has initiated the FORWARD Phase III trial evaluating AXS-14 for the management of fibromyalgia, with the ...
The use of GLP-1 receptor agonists was linked to lower pain and fatigue in patients with fibromyalgia, according to a large-scale health records analysis. Researchers used the TriNetX database to ...
When a patient with fibromyalgia is not responding to standard treatments, adding a noninvasive brain therapy might help them feel better. Repetitive transcranial magnetic stimulation (rTMS) of the ...
TNX-102 SL is the first new fibromyalgia treatment approved in over 15 years, joining three other treatments. Phase 3 trials showed significant pain reduction and good tolerance, with improvements in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback